Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Southan

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Genetics|January 2, 2014
A tale of two drug targets: the evolutionary history of BACE1 and BACE2Christopher Southan, John M Hancock
RSC Medicinal Chemistry|August 27, 2021
Will the chemical probes please stand up?Ctibor Škuta, Christopher Southan, Petr Bartůněk
Proteins|January 30, 2004
Splice variants: a homology modeling approachNicholas Furnham, Stuart Ruffle, Christopher Southan
Current Topics in Medicinal Chemistry|September 28, 2007
Complementarity between public and commercial databases: new opportunities in medicinal chemistry informaticsChristopher Southan, Péter Várkonyi, Sorel Muresan
Molecular Informatics|February 18, 2014
Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target DatabaseChristopher Southan, Markus Sitzmann, Sorel Muresan
F1000Research|August 1, 2015
Finding small molecules for the 'next Ebola'Sean Ekins, Christopher Southan, Megan Coffee
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2012
Mapping between databases of compounds and protein targetsSorel Muresan, Markus Sitzmann, Christopher Southan
Journal of Cheminformatics|March 20, 2010
Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compoundsChristopher Southan, Péter Várkonyi, Sorel Muresan
Drug Discovery Today|November 20, 2012
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidatesChristopher Southan, Antony J Williams, Sean Ekins
Journal of Cheminformatics|May 17, 2011
Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffoldsChristopher Southan, Kiran Boppana, Sarma Arp Jagarlapudi, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Genetics|January 2, 2014
A tale of two drug targets: the evolutionary history of BACE1 and BACE2Christopher Southan, John M Hancock
RSC Medicinal Chemistry|August 27, 2021
Will the chemical probes please stand up?Ctibor Škuta, Christopher Southan, Petr Bartůněk
Proteins|January 30, 2004
Splice variants: a homology modeling approachNicholas Furnham, Stuart Ruffle, Christopher Southan
Current Topics in Medicinal Chemistry|September 28, 2007
Complementarity between public and commercial databases: new opportunities in medicinal chemistry informaticsChristopher Southan, Péter Várkonyi, Sorel Muresan
Molecular Informatics|February 18, 2014
Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target DatabaseChristopher Southan, Markus Sitzmann, Sorel Muresan
F1000Research|August 1, 2015
Finding small molecules for the 'next Ebola'Sean Ekins, Christopher Southan, Megan Coffee
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2012
Mapping between databases of compounds and protein targetsSorel Muresan, Markus Sitzmann, Christopher Southan
Journal of Cheminformatics|March 20, 2010
Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compoundsChristopher Southan, Péter Várkonyi, Sorel Muresan
Drug Discovery Today|November 20, 2012
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidatesChristopher Southan, Antony J Williams, Sean Ekins
Journal of Cheminformatics|May 17, 2011
Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffoldsChristopher Southan, Kiran Boppana, Sarma Arp Jagarlapudi, et al.
Pageof 9